3b Blackbio Dx Ltd vs Krsnaa Diagnostics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of 3B Blackbio DX Ltd is ₹ 1332 as of 23 Oct 15:30 . The P/E Ratio of 3B Blackbio DX Ltd changed from 1.9 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe P/E Ratio of Krsnaa Diagnostics Ltd changed from 22.3 on March 2022 to 16.7 on March 2026 . This represents a CAGR of -5.62% over 5 years The Market Cap of 3B Blackbio DX Ltd changed from ₹ 213.76 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Krsnaa Diagnostics Ltd changed from ₹ 1524 crore on March 2022 to ₹ 1690 crore on March 2026 . This represents a CAGR of 2.09% over 5 years The revenue of 3B Blackbio DX Ltd for the Jun '26 is ₹ 39.63 crore as compare to the Mar '26 revenue of ₹ 45.58 crore. This represent the decline of -13.05% The revenue of Krsnaa Diagnostics Ltd for the Jun '26 is ₹ 242.78 crore as compare to the Mar '26 revenue of ₹ 224.1 crore. This represent the growth of 8.34% The ebitda of 3B Blackbio DX Ltd for the Jun '26 is ₹ 14.67 crore as compare to the Mar '26 ebitda of ₹ 18.64 crore. This represent the decline of -21.3% The ebitda of Krsnaa Diagnostics Ltd for the Jun '26 is ₹ 65.23 crore as compare to the Mar '26 ebitda of ₹ 86.37 crore. This represent the decline of -24.48% The net profit of 3B Blackbio DX Ltd changed from ₹ 11.3 crore to ₹ 8.98 crore over 9 quarters. This represents a CAGR of -9.71% The net profit of Krsnaa Diagnostics Ltd changed from ₹ 17.92 crore to ₹ 16.55 crore over 9 quarters. This represents a CAGR of -3.47% The Dividend Payout of 3B Blackbio DX Ltd changed from 391.92 % on March 2021 to 8.69 % on March 2026 . This represents a CAGR of -47.00% over 6 yearsThe Dividend Payout of Krsnaa Diagnostics Ltd changed from 11.1 % on March 2022 to 6.32 % on March 2026 . This represents a CAGR of -10.65% over 5 years .

About 3B Blackbio DX Ltd

3D Blackbio DX Limited, formerly known as Kilpest India Limited was incorporated on May 25, 1972 as one of India's leading agro-business companies.
Thereafter, the holding Company, Kilpest India Limited got merged with 3B BlackBio Biotech India Limited and as per the Scheme of Amalgamation, the name of the Company was changed from Kilpest India Limited to 3B BlackBio DX Limited in August, 2023. The Company is a leading Indian biotech firm focused on molecular diagnostics (PCR kits, enzymes, reagents for diseases like cancer/ infectious diseases) under the 'TRUPCR' brand, alongside developing Next-Gen Sequencing (NGS) assays (TRUNGS) & Rapid Tests (TRURAPID), while continuing its traditional agrochemicals business (pesticides, bio-products), serving both labs and government sectors, driven by R&D for innovative solutions.

About Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited' at Pune, Maharashtra dated December 22, 2010.
The Company name was changed to Krsnaa Diagnostics Private Limited', pursuant to a fresh Certificate of Incorporation issued by the RoC on January 29, 2015.
Thereafter, the status got converted into a Public Company and the name was changed to Krsnaa Diagnostics Limited pursuant to a fresh Certificate of Incorporation issued by the RoC on 06 May, 2021. The Company is primarily engaged in providing diagnostic services centres all over India.
The Company is providing Radiology and Pathology services for X-ray, CT Scan, MRI, Mammography, Bone Densitometry, Ultrasound, Colout Doppler, Tele-Reporting services, all type of blood and urine investigation and other related diagnostic services.

FAQs for the comparison of 3B Blackbio DX Ltd and Krsnaa Diagnostics Ltd

Which company has a larger market capitalization, 3B Blackbio DX Ltd or Krsnaa Diagnostics Ltd?

Market cap of 3B Blackbio DX Ltd is 1,144 Cr while Market cap of Krsnaa Diagnostics Ltd is 1,614 Cr

What are the key factors driving the stock performance of 3B Blackbio DX Ltd and Krsnaa Diagnostics Ltd?

The stock performance of 3B Blackbio DX Ltd and Krsnaa Diagnostics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for 3B Blackbio DX Ltd and Krsnaa Diagnostics Ltd?

As of October 25, 2026, the 3B Blackbio DX Ltd stock price is INR ₹1332.95. On the other hand, Krsnaa Diagnostics Ltd stock price is INR ₹497.75.

How do dividend payouts of 3B Blackbio DX Ltd and Krsnaa Diagnostics Ltd compare?

To compare the dividend payouts of 3B Blackbio DX Ltd and Krsnaa Diagnostics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.